These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1374114)

  • 61. Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance.
    Cillo U; Urbani L; Carraro P; De Silvestro G; Boccagni P; Brolese A; Zanus G; Michielan F; Feltracco P; Fagiuoli S; Burra P; Piccoli A; D'Amico DF
    Transplant Proc; 2000 Dec; 32(8):2719-22. PubMed ID: 11134774
    [No Abstract]   [Full Text] [Related]  

  • 62. [Prognostic judgment of fulminant hepatitis by measurement of hepatosplenic volume ratio by computed tomography].
    Uetsuji S; Yamamura M; Komada H; Okuda Y; Hioki K; Uedono Y; Tanaka T
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):155-8. PubMed ID: 8464412
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure.
    Madl C; Grimm G; Ferenci P; Kramer L; Yeganehfar W; Oder W; Steininger R; Zauner C; Ratheiser K; Stockenhuber F
    Hepatology; 1994 Dec; 20(6):1487-94. PubMed ID: 7982649
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Hepatic regeneration factor in fulminent hepatitis and its dynamic changes].
    Okita K; Matsuda A; Handa T; Esaki T; Oda M; Takemoto T
    Nihon Rinsho; 1982; 40(4):837-42. PubMed ID: 6178860
    [No Abstract]   [Full Text] [Related]  

  • 65. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.
    Pereira LM; Langley PG; Hayllar KM; Tredger JM; Williams R
    Gut; 1992 Jan; 33(1):98-102. PubMed ID: 1740285
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Liver transplantation for fulminant hepatic failure.
    Ascher NL; Lake JR; Emond JC; Roberts JP
    Arch Surg; 1993 Jun; 128(6):677-82. PubMed ID: 8503773
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Indications for orthotopic liver transplantation in fulminant liver failure.
    Williams R; Wendon J
    Hepatology; 1994 Jul; 20(1 Pt 2):S5-10S. PubMed ID: 8005569
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fipexide-induced fulminant hepatitis. Report of three cases with emergency liver transplantation.
    Durand F; Samuel D; Bernuau J; Saliba F; Pariente EA; Marion S; Benhamou JP; Bismuth H
    J Hepatol; 1992 May; 15(1-2):144-6. PubMed ID: 1506632
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure.
    Sudan DL; Shaw BW; Fox IJ; Langnas AN
    Surgery; 1997 Oct; 122(4):771-7; discussion 777-8. PubMed ID: 9347855
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fulminant hepatic failure: pathophysiology, treatment, and survival.
    Atillasoy E; Berk PD
    Annu Rev Med; 1995; 46():181-91. PubMed ID: 7598455
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transplantation for fulminant hepatic failure.
    Lancet; 1990 Feb; 335(8686):407-9. PubMed ID: 1968130
    [No Abstract]   [Full Text] [Related]  

  • 72. Liver transplantation in the management of fulminant hepatic failure.
    Emond JC; Aran PP; Whitington PF; Broelsch CE; Baker AL
    Gastroenterology; 1989 Jun; 96(6):1583-8. PubMed ID: 2653944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure.
    Yoshiba M; Inoue K; Sekiyama K; Koh I
    Artif Organs; 1996 Nov; 20(11):1169-72. PubMed ID: 8908326
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Liver transplantation for acute hepatic failure?
    Chapman RW; Forman D; Peto R; Smallwood R
    Lancet; 1990 Jan; 335(8680):32-5. PubMed ID: 1967338
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B.
    Huo TI; Wu JC; Sheng WY; Chan CY; Hwang SJ; Chen TZ; Lee SD
    J Gastroenterol Hepatol; 1996 Jun; 11(6):560-5. PubMed ID: 8792311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum alpha-fetoprotein in fulminant hepatitis and hepatic regeneration following partial hepatectomy.
    Watanabe A; Shiota T; Hayashi S; Nagashima H
    Biochem Med; 1984 Aug; 32(1):132-7. PubMed ID: 6208897
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effect of artificial liver support system on the survival rate of high risk patients after liver transplantation].
    Li MR; Huang ZY; Cai CJ; Yi HM; An YL; Chen GH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jan; 22(1):12-5. PubMed ID: 20092702
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of acute and fulminant hepatitis A.
    O'Grady J
    Vaccine; 1992; 10 Suppl 1():S21-3. PubMed ID: 1476000
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of serum uric acid to creatinine ratio in fulminant hepatitis.
    Omori N; Ukida M; Mikami M; Morimoto Y; Tsuji T
    Acta Med Okayama; 1994 Jun; 48(3):159-64. PubMed ID: 7942073
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.